# Risk Factors Associated with the Emergence of Multidrug-Resistant Bacteria and Fungal Infections in Walled-Off Pancreatic Necrosis

**Authors:** Michael Fernandez Y Viesca, Alia Hadefi, Lukas Otero Sanchez, Martina Pezzullo, Morgane Van Wettere, Eleni Karakike, Maya Hites, Viviane De Maertelaer, Myriam Delhaye, Marianna Arvanitakis

PMC · DOI: 10.3390/antibiotics15020220 · Antibiotics · 2026-02-17

## TL;DR

This study identifies risk factors for multidrug-resistant bacteria in pancreatic infections, finding that antibiotic changes and nutritional support increase the risk.

## Contribution

The study identifies independent risk factors for MDR bacteria emergence in infected pancreatic necrosis.

## Key findings

- Antibiotic changes and nutritional support were independently linked to MDR bacteria emergence.
- ICU admission rates were higher in patients with IPN and MDR infections.
- Fungal infections showed no independent risk factors in this study.

## Abstract

Background: Infected pancreatic necrosis (IPN) is a serious complication of moderate-to-severe acute pancreatitis (AP), associated with high morbidity, intensive care unit (ICU) admission, organ failure, and mortality. Initial management relies on antibiotics and drainage of walled-off necrosis (WON). In the context of increasing multidrug-resistant (MDR) bacteria, identifying risk factors for MDR emergence is crucial. The impact of fungal infections (FIs) on outcomes also remains unclear. This study aimed to identify risk factors associated with the emergence of MDR bacteria and FIs during intervention for IPN. Methods: This retrospective study included 71 consecutive patients undergoing intervention for suspected IPN or symptomatic WON. Results: At first intervention, IPN was confirmed in 52 patients (73%), MDR bacteria in 19 (27%), extensively drug-resistant (XDR) bacteria in 4 (5.6%), and FI in 21 (30%). After all interventions, MDR/XDR bacteria and fungi were detected in 25 (35%)/11 (15.5%) and 42 (59%) patients, respectively. Independent risk factors for MDR emergence were the number of antibiotic changes (b, 1.70; 95% CI 1.18–2.43; p = 0.004) and need for nutritional support (NS) (b, 5.69; 95% CI 1.52–20.50; p = 0.010). No independent factor was associated with FI. The 180-day mortality did not differ across groups. The 90-day cumulative ICU admission rate was higher in IPN vs. non-IPN (63.1% vs. 29.4%, p = 0.030) and in MDR vs. non-MDR (72.2% vs. 37.1%, p = 0.005). Conclusions: Antibiotic changes and NS were independently associated with MDR emergence in IPN. No independent factors were linked to FI. ICU admission was significantly higher in IPN and MDR cases.

## Linked entities

- **Diseases:** acute pancreatitis (MONDO:0006515)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** injury to (MESH:D014947), inflammatory reaction (MESH:D007249), GPC (MESH:D016908), critically ill (MESH:D016638), pain (MESH:D010146), Infected pancreatic necrosis (MESH:D019283), Alcohol abuse (MESH:D000437), MDR (MESH:D018088), compression (MESH:D009408), systemic inflammatory response syndrome (MESH:D018746), gallstones (MESH:D042882), AP (MESH:D010195), organ dysfunction (MESH:D009102), PDR (MESH:D000069279), fever (MESH:D005334), NS (MESH:D044342), death (MESH:D003643), CP (MESH:D002972), XDR (MESH:D054908), Infected (MESH:D007239), toxicity (MESH:D064420), chronic calcifying pancreatitis (MESH:D050500), WON (MESH:D056988), FI (MESH:D061219), GNB (MESH:D016905), FIs (MESH:D009181), septic shock (MESH:D012772), necrosis (MESH:D009336), sepsis (MESH:D018805)
- **Chemicals:** aminoglycoside (MESH:D000617), nitroimidazole (MESH:D009593), metronidazole (MESH:D008795), lincosamide (MESH:D055231), carbapenem (MESH:D015780), posaconazole (MESH:C101425), voriconazole (MESH:D065819), penicillin + ss-lactamase inhibitor (-), penicillins (MESH:D010406), cephalosporin (MESH:D002511), fluoroquinolone (MESH:D024841), triazoles (MESH:D014230), fluconazole (MESH:D015725), CO2 (MESH:D002245), itraconazole (MESH:D017964), glycopeptide (MESH:D006020), cotrimoxazole (MESH:D015662), caspofungin (MESH:D000077336)
- **Species:** Candida albicans (species) [taxon 5476], Pichia kudriavzevii (species) [taxon 4909], Nakaseomyces glabratus (species) [taxon 5478], Veillonella parvula (species) [taxon 29466], Fungi (kingdom) [taxon 4751], Segatella buccae (species) [taxon 28126], Lactobacillus gasseri (species) [taxon 1596], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606], Fusobacterium nucleatum (species) [taxon 851]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938492/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938492/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938492/full.md

---
Source: https://tomesphere.com/paper/PMC12938492